Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 200 Total
ALUR - Allurion Technologies Inc - Stock Price Chart
TickerALUR [NYSE]
CompanyAllurion Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap112.61MEPS (ttm)-4.34
P/E-EPS this Y62.36%
Forward P/E-EPS next Y44.04%
PEG-EPS past 5Y-
P/S2.86EPS next 5Y-
P/B-EPS Q/Q-3253.12%
Dividend-Sales Q/Q-
Insider Own24.13%Inst Own19.11%
Insider Trans0.00%Inst Trans-8.36%
Short Float1.73%EarningsMay 14/b
Analyst Recom1.00Target Price5.00
Avg Volume1.02M52W Range1.56 - 10.94
Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chardon BenoitChief Commercial OfficerDec 12 '23Option Exercise1.19165,539197,562199,183Dec 14 07:17 PM
CABA - Cabaletta Bio Inc - Stock Price Chart
TickerCABA [NASD, RUT]
CompanyCabaletta Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap580.79MEPS (ttm)-1.66
P/E-EPS this Y-15.09%
Forward P/E-EPS next Y-10.08%
PEG-EPS past 5Y-26.63%
P/S-EPS next 5Y-
P/B2.51EPS Q/Q11.80%
Dividend-Sales Q/Q-
Insider Own18.86%Inst Own88.41%
Insider Trans-0.37%Inst Trans-19.73%
Short Float26.00%EarningsMar 21/b
Analyst Recom1.00Target Price34.11
Avg Volume1.12M52W Range9.02 - 26.35
Cabaletta Bio, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in April 2017 and is headquartered in Philadelphia, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Binder GwendolynSee RemarksJan 19 '24Option Exercise1.0111,00011,11031,000Jan 19 06:30 PM
Binder GwendolynSee RemarksJan 19 '24Sale19.5911,000215,43920,000Jan 19 06:30 PM
Binder GwendolynSee RemarksDec 19 '23Option Exercise1.0111,00011,11031,000Dec 19 08:37 PM
Binder GwendolynSee RemarksDec 19 '23Sale21.8911,000240,78920,000Dec 19 08:37 PM
Binder GwendolynSee RemarksNov 20 '23Option Exercise1.0111,00011,11031,000Nov 21 04:30 PM
TGTX - TG Therapeutics Inc - Stock Price Chart
TickerTGTX [NASD, RUT]
CompanyTG Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.45BEPS (ttm)0.01
P/E1126.24EPS this Y-184.72%
Forward P/E30.62EPS next Y780.09%
PEG-EPS past 5Y-
P/S10.50EPS next 5Y-
P/B14.98EPS Q/Q73.92%
Dividend-Sales Q/Q54863.75%
Insider Own9.56%Inst Own58.71%
Insider Trans-0.62%Inst Trans-5.76%
Short Float25.55%EarningsMay 01/b
Analyst Recom1.62Target Price28.29
Avg Volume3.50M52W Range6.46 - 35.67
TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lonial SagarDirectorMar 13 '24Sale15.945,00079,675108,878Mar 15 04:37 PM
Charney Laurence NDirectorMar 12 '24Sale15.9722,000351,340215,229Mar 13 04:52 PM
Charney Laurence NDirectorJan 05 '24Sale19.0317,500333,025237,229Jan 08 06:33 PM
Power Sean ACFOJan 03 '24Sale16.9147,867809,431606,969Jan 05 05:00 PM
WEISS MICHAEL SCEO and PresidentAug 11 '23Buy10.13100,0001,013,00012,073,021Aug 14 09:54 AM
TECH - Bio-Techne Corp - Stock Price Chart
TickerTECH [NASD, S&P 500]
CompanyBio-Techne Corp
CountryUSA
IndustryBiotechnology
Market Cap11.55BEPS (ttm)1.39
P/E52.97EPS this Y-11.43%
Forward P/E36.16EPS next Y15.26%
PEG9.53EPS past 5Y16.30%
P/S10.08EPS next 5Y5.56%
P/B5.88EPS Q/Q-44.48%
Dividend0.35%Sales Q/Q0.37%
Insider Own1.03%Inst Own100.57%
Insider Trans-0.64%Inst Trans1.98%
Short Float3.70%EarningsMay 01/b
Analyst Recom1.43Target Price82.02
Avg Volume1.11M52W Range51.79 - 89.91
Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nusse RoelandDirectorMar 07 '24Sale76.9810,400800,62743,097Mar 11 04:04 PM
Hippel JamesCFODec 19 '23Option Exercise31.2647,2891,478,254104,850Dec 21 04:06 PM
Nusse RoelandDirectorAug 30 '23Option Exercise22.4032,000716,80060,811Sep 01 04:06 PM
Nusse RoelandDirectorAug 30 '23Sale80.328,939717,95951,872Sep 01 04:06 PM
Kelderman KimPres. Diagnostics & GenomAug 24 '23Option Exercise47.602,10099,96021,225Aug 28 04:19 PM
PAVM - PAVmed Inc - Stock Price Chart
TickerPAVM [NASD]
CompanyPAVmed Inc
CountryUSA
IndustryMedical Devices
Market Cap21.18MEPS (ttm)-9.20
P/E-EPS this Y36.17%
Forward P/E-EPS next Y32.50%
PEG-EPS past 5Y6.21%
P/S8.65EPS next 5Y-
P/B-EPS Q/Q40.60%
Dividend-Sales Q/Q836.61%
Insider Own15.14%Inst Own12.38%
Insider Trans0.00%Inst Trans80.65%
Short Float5.23%EarningsMar 27/b
Analyst Recom1.50Target Price10.75
Avg Volume63.35K52W Range1.60 - 7.76
PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. The company's products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. PAVmed was founded on June 26, 2014 and is headquartered in New York, NY.
ILPT - Industrial Logistics Properties Trust - Stock Price Chart
TickerILPT [NASD]
CompanyIndustrial Logistics Properties Trust
CountryUSA
IndustryREIT - Industrial
Market Cap266.65MEPS (ttm)-1.65
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.61EPS next 5Y0.60%
P/B0.40EPS Q/Q-0.25%
Dividend0.99%Sales Q/Q2.40%
Insider Own1.79%Inst Own52.24%
Insider Trans0.00%Inst Trans1.34%
Short Float1.01%EarningsApr 30/a
Analyst Recom2.33Target Price9.00
Avg Volume368.54K52W Range1.64 - 4.88
Industrial Logistics Properties Trust is a real estate investment trust, which owns and leases industrial and logistics properties. The company was founded on September 15, 2017 and is headquartered in Newton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PHELAN KEVIN CDirectorAug 09 '23Buy3.805,00019,0008,500Aug 10 05:04 PM
JONES LISA HARRISDirectorJul 27 '23Buy3.7750,000188,39070,000Jul 31 07:50 AM
Morea JosephDirectorJul 27 '23Buy3.6820,00073,65440,000Jul 31 07:52 AM
JONES LISA HARRISDirectorMay 04 '23Sale2.0019,65939,3320May 05 04:55 PM
Morea JosephDirectorMay 03 '23Sale2.0717,50036,2930May 03 07:08 PM
WVE - Wave Life Sciences Ltd. - Stock Price Chart
TickerWVE [NASD, RUT]
CompanyWave Life Sciences Ltd.
CountrySingapore
IndustryBiotechnology
Market Cap693.55MEPS (ttm)-0.55
P/E-EPS this Y-87.04%
Forward P/E-EPS next Y-5.74%
PEG-EPS past 5Y36.03%
P/S6.12EPS next 5Y-
P/B17.05EPS Q/Q68.11%
Dividend-Sales Q/Q2245.12%
Insider Own21.20%Inst Own74.59%
Insider Trans19.79%Inst Trans-0.41%
Short Float3.27%EarningsMar 06/b
Analyst Recom1.50Target Price13.00
Avg Volume891.72K52W Range3.15 - 7.67
Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moran KyleChief Financial OfficerApr 03 '24Sale6.1715,63096,42133,921Apr 05 08:00 PM
RA CAPITAL MANAGEMENT, L.P.DirectorDec 11 '23Buy5.001,000,0005,000,00019,202,009Dec 13 04:33 PM
GSK plc10% OwnerDec 07 '23Buy5.003,300,00016,500,00013,983,761Jan 30 04:39 PM
Moran KyleChief Financial OfficerAug 23 '23Sale4.7537,062176,11946,120Aug 23 09:15 PM
CRS - Carpenter Technology Corp. - Stock Price Chart
TickerCRS [NYSE, RUT]
CompanyCarpenter Technology Corp.
CountryUSA
IndustryMetal Fabrication
Market Cap4.86BEPS (ttm)2.88
P/E34.17EPS this Y253.73%
Forward P/E19.53EPS next Y24.86%
PEG1.49EPS past 5Y-21.93%
P/S1.78EPS next 5Y22.87%
P/B3.30EPS Q/Q581.61%
Dividend0.81%Sales Q/Q7.79%
Insider Own3.03%Inst Own92.04%
Insider Trans-0.25%Inst Trans-3.42%
Short Float3.02%EarningsMay 01/b
Analyst Recom1.40Target Price99.67
Avg Volume485.89K52W Range44.40 - 86.79
Carpenter Technology Corp. engages in the manufacturing, fabrication, and distribution of specialty metals. It operates through the Specialty Alloys Operations and Performance Engineered Products segments. The Specialty Alloys Operations segment is composed of its major premium alloy and stainless-steel manufacturing operations. The Performance Engineered Products segment includes the Dynamet titanium, Carpenter Additive, and the Latrobe and Mexico distribution businesses. The company was founded by James Carpenter in 1889 and is headquartered in Philadelphia, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCLANE CHARLES DOUGLAS JRDirectorNov 07 '23Sale66.423,791251,7986,459Nov 08 04:48 PM
MCLANE CHARLES DOUGLAS JRDirectorNov 06 '23Option Exercise23.4415,734368,79815,734Nov 08 04:48 PM
WARD JR STEPHEN MDirectorOct 15 '23Option Exercise59.321,22772,78622,755Oct 17 04:12 PM
INGLIS I MARTINDirectorOct 15 '23Option Exercise59.321,22772,7864,827Oct 17 04:09 PM
KAROL STEVEN EDirectorSep 20 '23Option Exercise59.321,22772,786181,227Sep 21 04:45 PM
UFPT - UFP Technologies Inc. - Stock Price Chart
TickerUFPT [NASD, RUT]
CompanyUFP Technologies Inc.
CountryUSA
IndustryMedical Devices
Market Cap1.80BEPS (ttm)5.84
P/E40.42EPS this Y7.59%
Forward P/E32.85EPS next Y7.81%
PEG-EPS past 5Y24.81%
P/S4.50EPS next 5Y-
P/B6.30EPS Q/Q36.77%
Dividend-Sales Q/Q11.25%
Insider Own6.05%Inst Own90.86%
Insider Trans-17.26%Inst Trans-1.04%
Short Float3.26%EarningsMay 01/b
Analyst Recom1.67Target Price262.50
Avg Volume64.51K52W Range127.29 - 257.29
UFP Technologies, Inc. engages in designing and custom manufacturing of components, subassemblies, products and packaging utilizing specialized foams, films, and plastics primarily for the medical market. The firm manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. The firm also providing highly engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets. Its products include military uniform and gear components, automotive interior trim, athletic padding, environmentally friendly protective packaging, air filtration, abrasive nail files, and protective cases and inserts. The company was founded by Richard L. Bailly, Robert W. Drew, Sr. and William H. Shaw in 1963 and is headquartered in Newburyport, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OBERDORF THOMASDirectorApr 25 '24Option Exercise25.042,08852,2845,777Apr 29 06:44 PM
Cardin SteveVice PresidentMar 13 '24Sale198.00604119,5925,039Mar 15 05:44 PM
FELDMANN CYNTHIA LDirectorFeb 23 '24Option Exercise31.201,72453,7896,190Feb 27 05:18 PM
BAILLY R JEFFREYCEOFeb 23 '24Sale209.4827,0905,674,6820Feb 27 06:13 PM
Litterio Christopher P.Senior Vice PresidentFeb 23 '24Sale208.652,000417,30614,334Feb 27 05:15 PM
PSTX - Poseida Therapeutics Inc - Stock Price Chart
TickerPSTX [NASD, RUT]
CompanyPoseida Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap268.50MEPS (ttm)-1.38
P/E-EPS this Y-18.80%
Forward P/E-EPS next Y-8.60%
PEG-EPS past 5Y-12.83%
P/S4.15EPS next 5Y2.70%
P/B2.55EPS Q/Q31.60%
Dividend-Sales Q/Q148.68%
Insider Own35.96%Inst Own46.86%
Insider Trans0.00%Inst Trans57.20%
Short Float6.52%EarningsMar 07/a
Analyst Recom1.00Target Price14.00
Avg Volume717.83K52W Range1.54 - 4.27
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
1234567891020